RT Book, Section
A1 Moore, Thomas A.
A2 Kasper, Dennis L.
A2 Fauci, Anthony S.
SR Print(0)
ID 1141413131
T1 AGENTS USED TO TREAT PARASITIC INFECTIONS
T2 Harrison's Infectious Diseases, 3e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9781259835971
LK accessbiomedicalscience.mhmedical.com/content.aspx?aid=1141413131
RD 2024/04/18
AB Parasitic  infections  afflict  more  than  half  of  the  world’s  population  and  impose  a  substantial  health  burden,  particularly  in  underdeveloped  nations,  where  they  are  most  prevalent.  The  reach  of  some  parasitic  diseases,  including  malaria,  has  expanded  over  the  past  few  decades  as  a  result  of  factors  such  as  deforestation,  population  shifts,  global  warming,  and  other  climatic  events.  Despite  major  efforts  at  vaccine  development  and  vector  control,  chemotherapy  remains  the  single  most  effective  means  of  controlling  parasitic  infections.  Efforts  to  combat  the  spread  of  some  diseases  are  hindered  by  the  development  and  spread  of  drug  resistance,  the  limited  introduction  of  new  antiparasitic  agents,  and  the  proliferation  of  counterfeit  medications.  However,  there  are  good  reasons  to  be  optimistic.  Ambitious  global  initiatives  aimed  at  controlling  or  eliminating  threats  such  as  AIDS,  tuberculosis,  and  malaria  have  demonstrated  some  early  successes.  Recognition  of  the  substantial  burden  imposed  by  the  “neglected”  tropical  diseases  has  generated  multinational  partnerships  to  develop  and  deploy  effective  antiparasitic  agents.  Vaccines  against  several  tropical  diseases  are  being  developed,  and  clinical  trials  for  vaccines  against  parasites  continue.